3.670EUR+11.21%Mkt Cap: 217.25M EURP/E: —Last update: 2026-06-01
Carvolix SA, a medical technology company, develops and markets minimally invasive minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechan…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap217.25M EUR
Enterprise Value—
Revenue (TTM)900.00K EUR
Gross Profit856.00K EUR
Net Income (TTM)-14.74M EUR
Revenue/Share—
Last Price3.670 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0013333077
Valuation
P/E (Trailing)—
P/E (Forward)-8.67
PEG—
EV/EBITDA—
EV/Revenue—
P/S217.06
P/B6.16
EPS (TTM)-0.64
EPS (Forward)-0.38
52W Range
1.82554% of range5.220
52W High5.220 EUR
52W Low1.825 EUR
Profitability
Gross Margin20.79%
Oper. Margin-2469.04%
EBITDA Margin0.00%
Profit Margin-357.92%
ROE-48.69%
ROA-24.22%
Growth
Revenue Growth-93.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.32M EUR
CapEx (TTM)147.00K EUR
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.54
Current Ratio—
Quick Ratio—
Book Value/Sh0.5360 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)4.933 EUR
Target Range4.500 EUR – 5.300 EUR
# Analysts3
Ownership
Shares Out.59.20M
Float—
Insiders16.70%
Institutions68.98%
Technical
SMA 503.104 (+18.2%)
SMA 2003.154 (+16.3%)
Beta0.97
S&P 52W Chg27.94%
Avg Vol (30d)23.09K
Avg Vol (10d)19.37K
Technical Indicators
RSI (14)60.0
MACD0.0245
MACD Signal0.0023
MACD Hist.+0.0222
BB Upper3.305 EUR
BB Middle3.126 EUR
BB Lower2.946 EUR
BB Width11.47%
ATR (14)0.1770 EUR
Vol Ratio (20d)1.23x